Brief: IRLAB Q3 Adj, EPS at SEK -0.74
25/10/2023 06:06
Oct 25 (Reuters) - IRLAB Q3 EBIT SEK -40.7 million. * Q3 adjusted EPS SEK -0.74
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK165.12m
- SEK155.10m
- SEK57.46m
Last trade - 00:00